The Role of FDG-PET and Staging Laparoscopy in the Management of Patients with Cancer of the Esophagus or Gastroesophageal Junction

Harry H. Yoon, Val J. Lowe, Stephen D. Cassivi, Yvonne Romero

Research output: Contribution to journalReview article

7 Scopus citations

Abstract

The effort to improve outcomes in esophageal cancer has included attempts at improving staging and patient selection. 2-Deoxy-2-[18F]fluoro-Dglucose positron emission tomography (FDG-PET) has been extensively studied in this context and has been widely accepted as a staging tool. Its role in restaging or assessing therapeutic response is investigational and promising. Laparoscopy has also been studied as a means for improving staging, but its role may be limited in the era of PET. This article discusses the literature assessing these modalities, particularly with regard to the practical management of the patient in the clinic.

Original languageEnglish (US)
Pages (from-to)105-120
Number of pages16
JournalGastroenterology Clinics of North America
Volume38
Issue number1
DOIs
StatePublished - Mar 1 2009

Keywords

  • CT
  • Esophageal cancer
  • Gastroesophageal junction cancer
  • PET
  • Prognosis
  • Staging
  • Staging laparoscopy
  • Treatment response

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'The Role of FDG-PET and Staging Laparoscopy in the Management of Patients with Cancer of the Esophagus or Gastroesophageal Junction'. Together they form a unique fingerprint.

  • Cite this